Increasing obese population will stimulate the growth of the LDL test market

2018-04-24 13:48:12

According to a new report published by Reports Monitor titled, “Global LDL Test Market, Growth Opportunities, Innovations and Forecast, 2018-2025,”the LDL Test Market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025. 

Low density lipoprotein is referred to bad cholesterol as they carries cholesterol in blood and deposits in the blood vessels. Increasing obese population are on the verge of cardiovascular diseases this can be caused by presence of high level of low density lipoprotein which led to increases the LDL test market

According to WHO 17.7 million people die each year due to cardiovascular diseases which counts approximate 31% of all death globally. Many initiative by WHO to tackle the problems fuels to the LDL test market.  

This report provides a detailed analysis of LDL test market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter’s analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.

Request a Sample Copy @

The global LDL test market is majorly segmented on the basis of type, component, disease type and end user. Based on the type the market is segmented into LDL-C, LDL-P and LDL-B. on the basis of component the market is segmented into kits & reagent and devices. On the basis of disease type the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease and others. On the basis of end user the market is segmented into hospitals, clinics, research laboratory and ambulatory care.    

The global LDL test market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Increased number of population with high level of LDL and developed healthcare infrastructure are driving the growth of the market in North America. Rising population, disposal income, healthcare education and changing lifestyle propels the growth of the market in Asia-Pacific region.   

The major key players operating in the market are: Quest Diagnostics Incorporated, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckon Diagnostics, DiaSys Diagnostics India Private Limited, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America, Eurofins Scientific, Eurolyser Diagnostica GmbH, Sigma-Aldrich Co. LLC., Atlas Medical Uk, Diazyme Laboratories, Inc. and Thermo Fisher Scientific.

About Garner Insights:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected] 

Related Press Releases